Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: The Republican governor said the state is gradually moving into stage one of the state's recovery plan at 5 p.m. Friday, after 14 days of plateauing of key hospital metrics. He also said the decision came after consultation with a state team of public health experts and business leaders. "I want to be very clear: while lifting the stay at home order and gradually moving into stage one of our recovery is a positive step forward, it does not mean that we are safe or that this crisis is over," Hogan said at a news conference. "Low risk does not mean no risk. All Marylanders, particularly those older and more vulnerable populations, are advised to continue staying home as much as possible." Retail stores may reopen at up to 50% capacity, with curbside pickup and delivery strongly encouraged and all public health precautions in place. Examples of businesses that may reopen include clothing and shoe stores, pet groomers, animal adoption shelters, car washes, art galleries and bookstores. All manufacturing may resume operations, with multiple shifts encouraged. Churches and houses of worship may start holding religious services, at up to 50% capacity, with outdoor services strongly encouraged. Some personal services, including barbershops and hair salons, may open with up to 50% capacity and by appointment only. Maryland residents are still urged to work from home if they can. A requirement that people wear masks in public areas indoors will remain in effect. Limits prohibiting gatherings of 10 or more people will remain in place, with the exception of religious gatherings. The plan provides a flexible and community-based approach that enables individual jurisdictions to make decisions on the timing of stage one reopenings. Local governments can keep restrictions in place, but they can only act within the guidelines announced by the governor. Hogan noted that officials in two of Maryland's largest jurisdictions, Montgomery and Prince George's counties in the suburbs of the nation's capital, have made clear they are not ready to move into stage one. Of the state's 34,812 confirmed cases, 10,072 are in Prince George's, and 7,283 are in Montgomery. Baltimore County has 4,160 cases, and the city of Baltimore has the fourth-highest number with 3,476. Hogan also noted that other counties in the state feel strongly that they are able to begin stage one. "As our state cautiously moves forward we fully understand that not all counties are in the same situation," Hogan said. "Just four of Maryland's 24 jurisdictions currently account for more than 70% of our state's total confirmed cases." Some counties in rural parts of the state have had far fewer cases. Foe example, Garrett County in western Maryland has had six confirmed cases. Somerset County, on Maryland's Eastern Shore, has reported 51 cases the second fewest number of confirmed cases for a Maryland jurisdiction. As of Wednesday morning, Maryland has confirmed 34,812 virus cases. That was 751 more cases than on Tuesday. Maryland also has had a total of 1,694 confirmed deaths, 51 more than on the day before. Maryland has had 138,762 negative test results. On Wednesday, 1,550 people were hospitalized in the state due to the virus. That's 13 less than on Tuesday. ___ For more AP coverage of the virus outbreak, visit https://apnews.com/VirusOutbreak or https://apnews.com/UnderstandingtheOutbreak.
[A]: Maryland governor eases restrictions caused by virus.

[Q]: "The story says that the average copayment for a month's supply of some of the topical NSAID medications is around $30. It would have been nice to include the cost of comparable oral medications. Although the story explains the available evidence comparing topical NSAIDs to oral pain relievers, highlights the limited number of direct comparisons, and carefully states the general consensus of experts, all of this solid reporting is undermined by a focus on personal anecdotal evidence over quantifiable benefits. Indeed, the reporter claims one medication provided immediate relief, a statement at odds with clinical trials that conclude that it usually takes hours for patients to feel the pain-relief effects of topical NSAIDs. The story summarizes the reported side effects of topical NSAIDS. What's more, the reporter points out that the potential risks in people who have other health problems or are taking other drugs have not been well studied. That insight is something we see too rarely. The story refers to a number of clinical trials and systematic reviews of the evidence. It highlights areas where evidence is lacking or inconclusive. It would have been helpful to point out that in placebo-controlled trials, almost as many people who received the placebo reported pain relief as did those who got the active medication. The story could have mentioned that the systematic review it referred to was published by the Cochrane Collaboration and also the sources of the other clinical trial reports, so that interested readers could more easily locate the original articles. The story does not exaggerate the common pains these drugs are intended to treat, but the personal anecdotes and opinions highlighted at the beginning and ending of the story are unrepresentative of the typical experiences reported by participants in clinical trials and create a powerful impression that is at odds with the evidence. The story includes quotes from several experts and points out that two of them have accepted consulting fees or research support from pharmaceutical companies. The essence of this story is an attempt to compare topical NSAIDs with pills and other pain treatments. As noted above, though, the story does not mention that most people with minor pains feel better after awhile even if they don't take any pain relief medication. It also should have mentioned that the difference between placebo and active treatment groups in the clinical trials is often slim. The story reports that only three topical NSAIDs (nonsteroidal anti-inflammatory drugs) are approved for sale with a prescription in the United States, while several brands are sold over the counter in Europe. Part of the focus of the story is that NSAIDS have been around for a long time but only recently are being given a more serious scientific reassessment. As the story says, ""But a number of new controlled trials and meta-analyses like Dr. Moore's suggest that topical Nsaids are as effective as their oral counterparts for treating osteoarthritis in the knee and hand as well as musculoskeletal injuries like soreness and tendinitis."" The story includes several experts and mentions multiple studies."
[A]: Topical Gel Catches Up With Pills for Relief

[Q]: Pollution composed of tiny particles from car exhaust, factory smokestacks and other sources is dangerous to everyone's health, and during pregnancy it's been linked to premature births and low birth weight. But scientists don't understand why, something that could affect care for women in highly polluted areas. One theory is that the particles lodge in mom's lungs and trigger potentially harmful inflammation. Tuesday, Belgian researchers reported another possibility, that any risk might be more direct. A novel scanning technique spotted a type of particle pollution sootlike black carbon on placentas donated by 28 new mothers, they reported in Nature Communications. The placenta nourishes a developing fetus and tries to block damaging substances in the mother's bloodstream. The Hasselt University team found the particles accumulated on the side of the placenta closest to the fetus, near where the umbilical cord emerges. That's not proof the soot actually crossed the placenta to reach the fetus or that it's responsible for any ill effects, cautioned Dr. Yoel Sadovsky of the University of Pittsburgh Medical Center, a leading placenta expert who wasn't involved with the new research. And it's a small study. Still, "just finding it at the placenta is important," Sadovsky said. "The next question would be how much of these black carbon particles need to be there to cause damage." Scientists already had some clues from animal studies that particles could reach the placenta, but Tuesday's study is a first with human placentas. The Belgian researchers developed a way to scan placenta samples using ultra-short pulses from a laser that made the black carbon particles flash a bright white light, so they could be measured. The researchers included placentas from 10 mothers who lived in areas with high pollution and 10 others from low areas. The higher the exposure to pollution, the more particles the researchers counted in the placentas. "As the fetal organs are under full development, this might have some health risks," said Hasselt environment and public health specialist Tim Nawrot, the study's senior author. He is doing additional research to try to tell. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.
[A]:
Study finds air pollution reaches placenta during pregnancy.